phrykt

Alnylam Pharmaceuticals (ALNY) shares outstanding: 133.9M

Alnylam Pharmaceuticals had 133.9M shares outstanding on Oct 23, 2026, up 1.4% from 132.1M a year earlier.

From Alnylam Pharmaceuticals's filings with the SEC · ALNY stock page

Alnylam Pharmaceuticals shares outstanding by year

123.0M2022125.5M2023129.0M2024132.1M2025133.9M2026

#1,003 of 3,715 US companies by shares outstanding · See the full ranking

Year endedShares outstandingChange
Oct 23, 2026133.9M+1%
Oct 24, 2025132.1M+2%
Oct 25, 2024129.0M+3%
Oct 27, 2023125.5M+2%
Oct 21, 2022123.0M–

Shares outstanding of similar companies

Companies in the same industry as Alnylam Pharmaceuticals, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.

CompanyShares outstanding, latest yearYear ended
Arrowhead Pharmaceuticals141.4MNov 5, 2026
Cytokinetics139.3MNov 2, 2026
PERRIGO138.8MOct 30, 2026
Aurinia Pharmaceuticals134.0MOct 29, 2026
Alnylam Pharmaceuticals133.9MOct 23, 2026
Amylyx Pharmaceuticals128.6MOct 26, 2026
Viking Therapeutics127.5MOct 15, 2026

Questions and answers

What is Alnylam Pharmaceuticals's shares outstanding?

Alnylam Pharmaceuticals had 133.9M shares outstanding on Oct 23, 2026, up 1.4% from 132.1M a year earlier.

Numbers as reported in Alnylam Pharmaceuticals's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology